 WON-SALEM, N.C., May 20, 2022 GLOBE NEWSWIRE -- ProKidney LP ProKidney, a leading clinical-stage cellular therapeutics company focused on the treatment of chronic kidney disease CKD and the prevention of both end-stage renal disease ESRD and the need for dialysis, today announced that Tim Bertram, PhD, Chief Executive Officer, will present at the following investor conferences: 